| 摘要 |
FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to agent comprising definite fumaric acid monoalkyl esters as salts or free acid individually or in combination with dialkyl fumarate for treatment of patients with polyarthritis or cerebrospinal sclerosis and responses of type "transplant against host". EFFECT: enhanced effectiveness and reduced toxicity of agent. 9 cl, 1 tbl, 11 ex
|
